Medifast (NYSE:MED) Posts Earnings Results, Beats Estimates By $0.50 EPS

Medifast (NYSE:MED - Get Free Report) posted its earnings results on Monday. The specialty retailer reported $0.35 EPS for the quarter, topping the consensus estimate of ($0.15) by $0.50, Zacks reports. Medifast had a net margin of 3.81% and a return on equity of 25.77%. The business had revenue of $140.16 million for the quarter, compared to the consensus estimate of $135.45 million. During the same period last year, the company earned $2.12 EPS. Medifast updated its Q4 2024 guidance to 0.100-0.650 EPS.

Medifast Stock Performance

Shares of NYSE MED traded up $1.63 during midday trading on Tuesday, reaching $20.44. The stock had a trading volume of 587,692 shares, compared to its average volume of 391,487. The firm has a market cap of $223.61 million, a price-to-earnings ratio of 7.63 and a beta of 1.13. Medifast has a twelve month low of $17.07 and a twelve month high of $76.42. The company's 50 day moving average price is $18.46 and its 200 day moving average price is $20.92.

Wall Street Analyst Weigh In

Separately, DA Davidson upgraded shares of Medifast from an "underperform" rating to a "neutral" rating and lifted their target price for the stock from $16.50 to $17.00 in a research report on Tuesday.

Medifast Company Profile

Medifast, Inc, through its subsidiaries, engages in the manufacture and sale of weight loss, weight management, and healthy living products in the United States and the Asia-Pacific. It offers bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brand names.